ORGAN PRESERVATION
Recipient Intramuscular
Administration of Naked Plasmid
TGF-1 Attenuates Lung Graft
Reperfusion Injury
Niccolo` Daddi, MD,
a
Samer A. Kanaan, MD,
a
Takashi Suda, MD,
a
Tsutomu Tagawa, MD,
a
Franco D’Ovidio, MD,
b
Kathleen Grapperhaus, BSc,
a
Benjamin D. Kozower, MD,
a
Jon H. Ritter, MD,
c
T. Mohanakumar, PhD,
a,d
and G. Alexander Patterson, MD, FRCS(C)
a
Background: Gene therapy may be an effective strategy for modulating lung graft
ischemia–reperfusion injury. We investigated whether recipient intramuscular (IM)
naked plasmid gene transfer of transforming growth factor 1–active (TGF-1–active)
ameliorates lung graft ischemia–reperfusion injury.
Methods: Preliminary studies in F344 rats demonstrated that gastrocnemius muscle
transfection of TGF-1–active produced muscle and plasma protein expression at 24
and 48 hours after transfection. Recipients (n 8) received IM injection of naked
plasmid-encoding chloramphenicol acetyl transferase (CAT), TGF-1–latent or TGF-
1–active, respectively, at 24 or at 48 hours before left lung transplantation. We did not
treat the control group before transplantation (18-hour cold ischemia). Donor lungs
were flushed with low-potassium dextran–1% glucose and stored for 18 hours at 4°C.
All groups were killed at 24 hours after transplantation. Immediately before killing the
animals, we clamped the contralateral right hilum and assessed graft function. We
measured wet-to-dry ratio (W/D), myeloperoxidase, pro-inflammatory cytokines
(interleukin 1 [IL-1], tumor necrosis factor [TNF-], interferon- [INF-], and IL-2)
and performed immunohistochemistry.
Results: Arterial oxygenation was greatest in the recipient group transfected with TGF-
1–active at 24 hours before transplantation compared with CAT, TGF-1–latent, and
18-hour cold ischemia groups (p 0.01). The W/D ratio and myeloperoxidase
decreased in both 24- and 48-hour groups, with TGF-1–active compared with CAT,
and 18-hour cold ischemia groups (W/D, p 0.02 and p 0.004, respectively;
myeloperoxidase, p 0.05 and p 0.01, respectively). All pro-inflammatory cytokines
decreased in the 24-hour TGF-1–active group compared with CAT, TGF-1–latent,
From the
a
Division of Cardiothoracic Surgery,
c
Department of
Pathology, and
d
Department of Immunology, Washington Uni-
versity School of Medicine, St. Louis, Missouri; and
b
Universita `
degli Studi di Bologna, Bologna, Italy.
This work is supported by National Institutes of Health Grants
RO1 HL-41281 (G.A.P.) and R01 HL56643 (T.M.). S.A.K. is
supported by individual NRSA-NIH Grant 1F32HL68401-01.
Presented in the poster session of the 21st Annual Meeting and
Scientific Session of the International Society for Heart and
Lung Transplantation, Vancouver, Canada, April 25–28, 2001.
Reprint requests: G. Alexander Patterson, MD, 3108 Queeny
Tower, One Barnes-Jewish Hospital Plaza, St. Louis, Missouri
63110. Telephone: 314-362-6025. Fax: 314-362-0328. E-mail:
pattersona@msnotes.wustl.edu
Copyright © 2003 by the International Society for Heart and
Lung Transplantation.
1053-2498/03/$–see front matter
doi:10.1016/j.healun.2003.09.011
1323